RecruitingNCT06208943

Neural and Cognitive Consequences of COVID-19 Survival


Sponsor

San Francisco Veterans Affairs Medical Center

Enrollment

150 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The novel coronavirus SARS-CoV-2 infection, COVID, continues to rage throughout the world with 115,000,000 confirmed cases and over 2,500,000 deaths (as of Mar 3, 2021). This translates to millions of people surviving COVID19 infection. While the lungs are ground zero, COVID tears through organ systems from brain to blood vessels. We are now beginning to see people recover but complain of ongoing problems, including lingering cognitive problems, depression, and anxiety. We have brought together 2 laboratories with complementary techniques including psychological testing and neuroimaging methods togethers with markers in the blood that may signal damage in the brain. A close look at these problems is timely and imperative if we are to understand the pathophysiology of 'COVID brain' and prepare for downstream problems.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria5

  • Our studies require some in-person visits to our research lab, located at 42nd Ave and Clement St in San Francisco.
  • Because this study includes an MRI, part of the screening process will be to ensure you don't have any metal in your body, you do not have head or neck tattoos, and you are comfortable inside the MRI scanner.
  • years with a confirmed COVID infection at least 3 months ago.
  • Negative metal screen for MRI safety
  • Normal (or corrected to normal) vision

Exclusion Criteria7

  • Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive symptoms)
  • Loss of consciousness (LOC) greater than 30 minutes or any LOC with neurologic symptoms
  • Major medical conditions (e.g., seizures disorders, treatment with anticonvulsant medication, endocrine disorders, significant cardiac pathology)
  • Substance dependence, within the past year, or failed urine toxicology on the day of neuroimaging sessions
  • Known claustrophobia
  • Current pregnancy
  • IQ estimate \< 70

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcross-sectional MRI and EEG assessments (NO INTERVENTION)

n/a there is no intervention in this observational study


Locations(1)

San Francisco Heathcare System

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06208943


Related Trials